Free Trial
OTCMKTS:CVAT

Cavitation Technologies (CVAT) Stock Price, News & Analysis

Cavitation Technologies logo
$0.02 0.00 (0.00%)
As of 07/3/2025

About Cavitation Technologies Stock (OTCMKTS:CVAT)

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.03
52-Week Range
$0.00
$0.04
Volume
N/A
Average Volume
375,729 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CVAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cavitation Technologies and its competitors with MarketBeat's FREE daily newsletter.

CVAT Stock News Headlines

CTI Welcomes a New Member to the Advisory Board
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
EQS-News: CTI Welcomes a New Member to the Advisory Board
Review: Atomic Maven 103 CTi
See More Headlines

CVAT Stock Analysis - Frequently Asked Questions

Cavitation Technologies' stock was trading at $0.0189 at the beginning of 2025. Since then, CVAT shares have increased by 22.8% and is now trading at $0.0232.

Shares of CVAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cavitation Technologies investors own include Adamis Pharmaceuticals (ADMP), Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Altimmune (ALT) and Digital Ally Inc./NV (DGLY).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Specialty Industrial Machinery
Sub-Industry
Agriculture
Current Symbol
OTCMKTS:CVAT
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:CVAT) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners